Tula, Tula, Russian Federation
Tula, Tula, Russian Federation
UDC 61
Pulmonary mycobacteriosis caused by nontuberculous mycobacteria (NTM) is a chronic infectious disease characterized by a prolonged, often oligosymptomatic course and significant diagnostic challenges. The most common pathogen in immunocompetent patients is Mycobacterium avium complex (MAC), which primarily affects the bronchopulmonary system in individuals with predisposing factors such as bronchiectasis, chronic obstructive pulmonary disease, or a history of viral respiratory infections. This paper presents a clinical case of a 56-year-old female patient with bronchiectatic disease, in whom pulmonary mycobacteriosis was diagnosed based on comprehensive evaluation including computed tomography of the chest, bronchoscopy with bronchoalveolar lavage, and microbiological as well as molecular-genetic studies.
nontuberculous mycobacteriosis; Mycobacterium avium complex; bronchiectatic disease; chronic pulmonary inflammation; clinical case
1. Klinicheskie rekomendacii. Mikobakteriozy organov dyhaniya. — M.: Ministerstvo zdravoohraneniya Rossiyskoy Federacii, 2022. — 68 s. — Rezhim dostupa: https://diseases.medelement.com/disease/ntm-infekcii-kp-2022/18132 (data obrascheniya: 25.10.2025).
2. World Health Organization. Global Tuberculosis Report 2024. — Geneva: WHO; 2024. — Rezhim dostupa: https://www.who.int/publications/i/item/9789240099302 (data obrascheniya: 27.10.2025).
3. Federal'naya sluzhba po nadzoru v sfere zaschity prav potrebiteley i blagopoluchiya cheloveka (Rospotrebnadzor). Epidemiologicheskaya situaciya po netuberkuleznym mikobakteriozam v Rossiyskoy Federacii, 2024. — Rezhim dostupa: https://rospotrebnadzor.ru/activities/statistical-materials/ (data obrascheniya: 29.10.2025).
4. Kiseleva I.A., Kulikova T.A., Makarova E.V. Postkovidnye izmeneniya dyhatel'nyh putey i ih rol' v razvitii netuberkuleznyh mikobakteriozov. Vestnik klinicheskoy mediciny. 2022; 8(1): 45–52. DOI:https://doi.org/10.36791/VKM.2022.8(1).45.
5. Grigor'eva T.N., Yakovleva I.N. Klinicheskie formy legochnogo mikobakterioza u pacientov s bronhoektazami. Pul'monologiya. 2021; 31(5): 623–630. DOI:https://doi.org/10.18093/0869-0189-2021-31-5-623-630.
6. Kulikova T.A., Kiseleva I.A. Netuberkuleznye mikobakterii v praktike pul'monologa: epidemiologiya, patogenez, diagnostika. Medicinskiy al'manah. 2020; 62(3): 47–53. DOI:https://doi.org/10.21145/2499-9954-2020-62-3-47-53.
7. Daley C.L., Iaccarino J.M., Lange C. et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. European Respiratory Journal. 2020; 56(1): 2000535. DOI:https://doi.org/10.1183/13993003.00535-2020.
8. Diel R., et al. Nontuberculous mycobacterial pulmonary disease: Epidemiology, diagnosis and treatment update 2023. European Respiratory Review. 2023; 32(169): 220214. DOI:https://doi.org/10.1183/16000617.0214-2022.
9. Kiseleva I.A., Yakovleva I.N., Grigor'eva T.N. Lechenie netuberkuleznyh mikobakteriozov legkih u pacientov s hronicheskimi bronholegochnymi zabolevaniyami. Vestnik sovremennoy klinicheskoy mediciny. 2023; 16(2): 84–91. DOI:https://doi.org/10.20969/VSKM.2023.16(2).84-91.
